实验性心力衰竭对心房细胞和离子电生理学的影响
Circulation
|June 7, 2000
概括
充血性心力衰竭 (CHF) 通过减少关键离子电流和增加交换器电流来改变心房电生理学. 这种重塑为心房动 (AF) 创造了一个基质,增加了它的持续时间.
科学领域:
- 心血管生理学心血管生理学
- 心脏电生理学 心脏电生理学
- 心脏衰竭研究研究
背景情况:
- 充血性心力衰竭 (CHF) 与心房动 (AF) 密切相关.
- 慢性心血管衰竭对心房细胞电生理学的具体影响仍然在很大程度上是未知的.
- 了解这些变化对于治疗CHF患者的AF至关重要.
研究的目的:
- 研究试验性充血性心力衰竭 (CHF) 对心房肌细胞电生理学的影响.
- 在CHF的背景下,确定有助于AF的特定离子电流变化.
主要方法:
- 通过心室节拍 (5周内每分钟220-240次) 诱导狗的慢性心血管衰竭.
- 在隔离的心房肌细胞中测量动力电位 (AP) 特性和离子电流.
- 在CHF和对照组之间比较电生理学参数.
主要成果:
- 来自CHF狗的心房肌细胞表现出高缩.
- 观察到L型Ca2+电流 (I(Ca) 的显著减少,短暂的向外K2+电流 (I(to) 和缓慢的延迟整流器K2+电流 (I(Ks)) 的显著减少.
- 纳+) /2+) 交换器 (NCX) 电流增加,而其他电流保持不变.
- 慢性心脏不全使心房动作潜力的持续时间更快,并且显著增加了平均AF持续时间.
结论:
- 实验性CHF选择性地改变了心房离子通道功能,降低了I,I,Ca和I,Ks,同时增加了NCX电流.
- 在CHF中这种电生理学重塑不同于在心房低心率中看到的.
- 这些CHF诱导的变化创造了一个有利于持续性心房动的基质.
相关概念视频
01:19Electrophysiology of Normal Cardiac Rhythm
The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase of...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:27Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...